Dose-Dense Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Node-Positive Breast Cancer

Background. Adding taxanes to anthracycline-based adjuvant chemotherapy has shown significant improvement in node-positive breast cancer patients but the optimal dose schedule has still remained undetermined. Objectives. The feasibility of dose-dense epirubicin in combination with cyclophosphamide (...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirzaei, Hamid Reza, Nasrollahi, Fatemeh, Mohammadi Yeganeh, Ladan, Jafari Naeini, Sepideh, Bikdeli, Pegah, Hajian, Parastoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172875/
https://www.ncbi.nlm.nih.gov/pubmed/25276426
http://dx.doi.org/10.1155/2014/259312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172875/
https://www.ncbi.nlm.nih.gov/pubmed/25276426
http://dx.doi.org/10.1155/2014/259312

Ejemplares similares